Element Materials Technology Bolsters European Medical Technologies Team

Element Materials Technology (Element) has appointed Dr Michael Kipping as Director of Medical Technologies for Europe, and Nicole Small as Senior Manager of the Medical Technology team.

Prior to joining Element, Michael was Health Innovation Lead at Innovate UK (UKRI) responsible for running the primary grant funding program that supports innovative UK health and life science businesses. He also worked closely with stakeholders in government, industry and academia to explore and develop a proposal for a UK Centre of Excellence for Regulatory Science & Innovation (UK CERSI).

Nicole was previously a senior manager at the Medicines and Healthcare Products Regulatory Agency (MHRA) Devices Safety and Surveillance division. She has led major change, educational and operational programs to ensure the safety of devices driven by benefit-risk assessments, and she led the agency’s COVID-19 response to secure the UK supply chain’s protective medical devices and PPE.

In his position at Element, Michael will drive the growth of the medical business across Europe.

Nicole will be forming a new team focused on enabling medical technology manufacturers to navigate the complex field of market access and the testing requirements necessary for safety and performance. She will also work with UK and European regulatory agencies and health institutions to expand Element’s service offering in that field.

Matt Hopkinson, EVP of EMEAA at Element, said: “We’re pleased to have Michael and Nicole join our team at Element. As we build a highly experienced and credible team supporting the medical industry, their medical device expertise across clinical, technical, regulatory and business applications will be an incredible asset. They will act as an essential bridge between Element’s world-class testing and assurance capabilities and the manufacturers, navigating highly complex and evolving requirements.

“A core part of our strategy includes the development of our medical end-market, and building our team of people with specific experience in the safety and performance of medical technologies will support that growth.”

Element provides comprehensive medical device services from feasibility and R&D, to product development and production quality control. It offers a full suite of medical device testing, including mechanical testing, product testing, material characterization and microbiological evaluation.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.